Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Menu

Alfuzosin Hcl 10 Mg Er 100 Tabs By Caraco Pharm Labs.

Image 0 of Alfuzosin Hcl 10 Mg Er 100 Tabs By Caraco Pharm Labs.Image 1 of Alfuzosin Hcl 10 Mg Er 100 Tabs By Caraco Pharm Labs.

Alfuzosin Hcl 10 Mg Er 100 Tabs By Caraco Pharm Labs.

Call for Price

Alfuzosin Hcl 10 Mg Er 100 Tabs By Caraco Pharm Labs. This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD4499612/RXB10106348/RXA312841
Size : 100
Selling UoM : EA
NDC: 47335-0956-88
UPC Barcode : 347335956887
Supplier: 0050001300 CARACO PHARM LABS
Supplier Material : 095688
Generic Code : 045052 ALFUZOSIN HCL ORAL TAB ER 24H 10 MG
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : GRX Gener

Have a question?

  Call for Price

Product Description.:

956
tablet , white , round round
White to off-whiteBiconvexDebossed

Each UROXATRAL extended-release tablet contains 10 mg alfuzosin hydrochloride as the active ingredient. Alfuzosin hydrochloride is a white to off-white crystalline powder that melts at approximately 240?C. It is freely soluble in water, sparingly soluble in alcohol, and practically insoluble in dichloromethane.

The tablet also contains the following inactive ingredients: colloidal silicon dioxide (NF), ethylcellulose (NF), hydrogenated castor oil (NF), hydroxypropyl methylcellulose (USP), magnesium stearate (NF), mannitol (USP), microcrystalline cellulose (NF), povidone (USP), and yellow ferric oxide (NF).

INDICATIONS

UROXATRAL is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. UROXATRAL is not indicated for the treatment of hypertension.
DOSAGE AND ADMINISTRATION

The recommended dosage is one 10 mg UROXATRAL (alfuzosin HCl) extended-release tablet once daily. The extent of absorption of Uroxatral is 50% lower under fasting conditions. Therefore, Uroxatral should be taken immediately after the same meal each day. The tablets should not be chewed or crushed.


SIDE EFFECTS
Clinical Studies Experience

Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.

The incidence of treatment-emergent adverse events has been ascertained from 3 placebo-controlled clinical trials involving 1,608 men where daily doses of 10 and 15 mg alfuzosin were evaluated. In these 3 trials, 473 men received UROXATRAL (alfuzosin HCl) 10 mg extended-release tablets. In these studies, 4% of patients taking UROXATRAL (alfuzosin HCl) 10 mg extended-release tablets withdrew from the study due to adverse events, compared with 3% in the placebo group.